SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJames Halstead Regulatory News (JHD)

Share Price Information for James Halstead (JHD)

Share Price is delayed by 15 minutes
Get Live Data
128.80    4.60 (3.70%)
Bid:
128.20
Ask:
129.60
Spread: 1.40 (1.092%)
Market Cap: £536.34m
JHD Live PriceLast checked at - London Stock Exchange

Intraday James Halstead Share Chart

Pre-close Trading Statement

25 Jan 2010 07:00

RNS Number : 0248G
James Halstead PLC
25 January 2010
 



25 January 2010

 

 

James Halstead plc

Pre-close Trading Statement

James Halstead plc, the commercial flooring manufacturer and distributor, is providing the following trading update prior to entering the close period ahead of its interim results for the six months to 31 December 2009.

James Halstead will announce these results on 31 March 2010.

The confidence expressed by the Chairman, Mr Geoffrey Halstead, at the Annual General Meeting, held on 4 December 2009, was well founded. In these challenging times, turnover and trading profit have continued to grow and will, in line with our expectations, be higher than the comparative period. 

Turnover of our overseas operations has been bolstered by the lower value of sterling but is ahead of last year even if these effects are excluded. Our UK turnover reflected difficult markets in this six month period though international sales in central Europe, New Zealand and Australia all show positive trends. Overall turnover is ahead 7%. 

As announced at the AGM, a special dividend of 15 pence per ordinary share is being paid to shareholders today. The Chairman noted at the AGM that the Board was minded to pay the interim dividend earlier this year, which would have the effect of moving the income from the 2010/11 tax year into the current tax year. The Board have decided to adopt this early payment and consequently the interim dividend of 8.0p per ordinary share (2009: 7.25p), an increase of 10.3%, will be paid on 31 March 2010 to those shareholders on the register at the close of business on 5 March 2010.

Commenting Mr Mark Halstead said:

"Several of our competitors are suffering lower sales, and there have been cut backs in infrastructure spend in many markets but we continue to progress. We have recently committed to capital expenditure of £4 million to upgrade our plant to increase productivity and capacity. This investment and new product developments, which are at an advanced stage, are measures of our continued confidence." 

-ends-

 

 

Enquiries:

James Halstead

0161 767 2500

Mark Halstead, Chief Executive

Gordon Oliver, Finance Director

Hudson Sandler

020 7796 4133

Nick Lyon / Michael Sandler 

Altium

020 7484 4040

Ben Thorne / Paul Chamberlain

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTDLLFLBFFBBBK
Date   Source Headline
9th Apr 20265:32 pmRNSGrant of Options
8th Apr 20265:19 pmRNSHolding(s) in Company
31st Mar 20267:00 amRNSInterim Results
23rd Feb 20264:48 pmRNSPDMR Acquisition of Shares
30th Jan 20263:32 pmRNSShare Buyback - Replacement
30th Jan 20262:44 pmRNSShare Buyback
29th Jan 20267:00 amRNSTrading Update
8th Jan 20268:20 amRNSBlock Listing Six Monthly Return
5th Dec 20251:00 pmRNSResult of AGM
5th Dec 20257:00 amRNSChairman’s Statement to the Annual General Meeting
14th Nov 202512:12 pmRNSDirector/PDMR Shareholding
14th Nov 202512:11 pmRNSDirector/PDMR Shareholding
17th Oct 20257:00 amRNSPosting of Annual Report and Notice of AGM
1st Oct 20257:00 amRNSPreliminary Results
8th Sep 20257:00 amRNSNotice of Preliminary Results
29th Aug 20253:55 pmRNSBLOCK LISTING SIX MONTHLY RETURN
29th Jul 20257:00 amRNSTrading Update
9th Apr 20255:32 pmRNSHolding(s) in Company
7th Apr 202512:25 pmRNSDirector/PDMR Shareholding
27th Mar 20257:00 amRNSInterim Results
6th Mar 202510:41 amRNSNotice of Interim Results - Replacement
6th Mar 20259:00 amRNSNotice of Inteirm Results
6th Mar 20257:00 amRNSNotice of Interim Results
31st Jan 20257:00 amRNSTrading Update and Notice of Results
27th Jan 20255:09 pmRNSDirector/PDMR Shareholding
6th Jan 20253:15 pmRNSBlock Listing Six Monthly Return
6th Dec 20242:09 pmRNSResults of AGM
6th Dec 20247:00 amRNSAGM Statement
18th Oct 20249:20 amRNSPosting of Annual R&A and Notice of AGM
1st Oct 20247:00 amRNSBoard Changes
1st Oct 20247:00 amRNSPreliminary Results
7th Aug 20248:05 amRNSBlock Listing Six Monthly Return
31st Jul 20247:00 amRNSTrading Update
15th Jul 20247:00 amRNSChange of Broker
8th Apr 20244:54 pmRNSPDMR Exercise of Share Options
3rd Apr 20242:00 pmRNSPDMR Acquisition of Shares
28th Mar 202412:00 pmRNSPDMR Grant of Share Options
27th Mar 20247:00 amRNSInterim Results
5th Mar 202412:30 pmRNSAppointment of Senior Independent Director
31st Jan 20247:00 amRNSTrading Update
4th Jan 20244:34 pmRNSBoard Changes
1st Dec 20232:25 pmRNSResults of Annual General Meeting
1st Dec 20237:00 amRNSAGM Statement
17th Nov 202311:13 amRNSPDMR Grant of Share Options
10th Nov 20234:45 pmRNSBlock Listing Six Monthly Return
10th Nov 20234:43 pmRNSBlock Listing Six Monthly Return
13th Oct 202312:00 pmRNSPosting of Annual R&A and Notice of AGM
2nd Oct 20237:00 amRNSPreliminary Results
1st Aug 20237:00 amRNSTrading Update
31st Mar 20231:57 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.